Fulgent Genetics, Inc.2024财年第二财季实现净利润-8.71百万美元，同比增加22.44%

自选股智能写手08-11

8月11日，Fulgent Genetics, Inc.（FLGT.US）公布财报，公告显示公司2024财年第二财季净利润为-8.71百万美元，同比增加22.44%；其中营业收入为71.03百万美元，同比增加4.69%，每股基本收益为-0.29美元。从资产负债表来看，Fulgent Genetics, Inc.（FLGT.US）总负债1.03亿美元，其中短期债务3.19百万美元，资产负债比为...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2458568299?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-08-11 00:18","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2458568299","market":"us","top_or_hot":-1,"title":"Fulgent Genetics, Inc.2024财年第二财季实现净利润-8.71百万美元，同比增加22.44%","media":"自选股智能写手","content":"<div>\n<p>8月11日，Fulgent Genetics, Inc.（FLGT.US）公布财报，公告显示公司2024财年第二财季净利润为-8.71百万美元，同比增加22.44%；其中营业收入为71.03百万美元，同比增加4.69%，每股基本收益为-0.29美元。从资产负债表来看，Fulgent Genetics, Inc.（FLGT.US）总负债1.03亿美元，其中短期债务3.19百万美元，资产负债比为...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408110018159f20499a&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Fulgent Genetics, Inc.2024财年第二财季实现净利润-8.71百万美元，同比增加22.44%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFulgent Genetics, Inc.2024财年第二财季实现净利润-8.71百万美元，同比增加22.44%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-08-11 00:18 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408110018159f20499a&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>8月11日，Fulgent Genetics, Inc.（FLGT.US）公布财报，公告显示公司2024财年第二财季净利润为-8.71百万美元，同比增加22.44%；其中营业收入为71.03百万美元，同比增加4.69%，每股基本收益为-0.29美元。从资产负债表来看，Fulgent Genetics, Inc.（FLGT.US）总负债1.03亿美元，其中短期债务3.19百万美元，资产负债比为...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408110018159f20499a&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408110018159f20499a&s=b","article_id":"2458568299","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408110018159f20499a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2458568299","pubTimestamp":1723306691,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"8月11日，Fulgent Genetics, Inc.公布财报，公告显示公司2024财年第二财季净利润为-8.71百万美元，同比增加22.44%；其中营业收入为71.03百万美元，同比增加4.69%，每股基本收益为-0.29美元。从资产负债表来看，Fulgent Genetics, Inc.总负债1.03亿美元，其中短期债务3.19百万美元，资产负债比为11.97，流动比率为0.06。机构评级：截至2024年8月11日，当前有3家机构对Fulgent Genetics, Inc.目标价做出预测，其中目标均价为27.67美元，其中最低目标价为26.00美元，最高目标价为30.00美元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":["earning"],"viewcount":null,"language":"zh","relate_stocks":{},"translate_title":"Fulgent Genetics, Inc. achieved net profit of-US $8.71 million in the second fiscal quarter of fiscal year 2024, a year-on-year increase of 22.44%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"FLGT":0.9},"content_text":"8月11日，Fulgent Genetics, Inc.（FLGT.US）公布财报，公告显示公司2024财年第二财季净利润为-8.71百万美元，同比增加22.44%；其中营业收入为71.03百万美元，同比增加4.69%，每股基本收益为-0.29美元。从资产负债表来看，Fulgent Genetics, Inc.（FLGT.US）总负债1.03亿美元，其中短期债务3.19百万美元，资产负债比为11.97，流动比率为0.06。机构评级：截至2024年8月11日，当前有3家机构对Fulgent Genetics, Inc.目标价做出预测，其中目标均价为27.67美元，其中最低目标价为26.00美元，最高目标价为30.00美元。公司简介：Fulgent Genetics Inc 是一家专注于基因检测的技术公司，为医生提供临床可操作的诊断信息。公司从事实验室服务业务和治疗开发业务。实验室服务业务产生的主要收入包括技术实验室服务和执业医师对实验室结果的专业解读。治疗开发业务主要致力于开发治疗各种癌症的候选药物。该公司的地理分部包括产生绝大部分收入美国和国外分部。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2458568299"}